Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00260572 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Minor2 versionsRe-verified since Oct 13, 2008, no change to tracked fieldsv7-v8
NotableEnrollment target: 500 to 1500Interventions: Questionnaire to evaluate presence or absence of pain (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)… to Questionnaire to evaluate presence or absence of pain (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)… · Site contact updatedv6Show 2 more changesShow less
Interventions: Questionnaire to evaluate presence or absence of pain (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)… to Questionnaire to evaluate presence or absence of pain (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)…
Site contact updated
Minor2 versionsRe-verified since Jul 25, 2006, no change to tracked fieldsv4-v5
MinorInterventions: Questionnaire to evaluate presence or absence of pain. (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)… to Questionnaire to evaluate presence or absence of pain (Behavioral), Questionnaire to evaluate satisfaction with treatment (Behavioral)…Study description revised · Eligibility criteria expanded, about 1 wordv3Show 2 more changesShow less
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aims of this study are to create a prospective data base to evaluate the long term outcomes of medical and surgical treatment of gastroesophageal reflux disease (GERD); to measure standard outcomes as well as patient derived outcomes such as general and disease specific quality of life (QOL) issues and patient satisfaction; to refine the parameters that may identify patients who will benefit from surgery for GERD; and to identify possible determinants of failure of both medical and surgical treatments of reflux.